Moreover, RNA-seq analyses confirmed the association of ERα-LBD expression with gene signatures related to breast cancer and signaling, drug resistance and cell metabolism, stemness, and adaptation to hypoxia (Fig. 7). The gene discussed is ESR1; the disease is breast carcinoma.